Philosophy of Care
Dr. Melnikow became a family practitioner because she likes caring for the whole patient in the context of his or her family and community. She is particularly interested in women's health care, especially preventive health maintenance. She enjoys caring for patients of all ages, especially children. She is pleased that the Family and Community Medicine clinic enables her to serve many in the community who are in need of health care, including maternal-child health care and preventive health services.
Dr. Melnikow is particularly interested in women's health care, including prenatal care, breast-feeding and preventive health maintenance. Her research areas include preventive services, prenatal care, patient compliance and physician behavior. She also studies underserved populations and ways to improve cost effectiveness in women's health care.
Family and Community Medicine
M.D., UC San Francisco School of Medicine, San Francisco, California, 1984
B.A., San Francisco State University, San Francisco, California, 1979
University of Massachusetts, Amherst, Massachusetts, 1984-1987
American Board of Family Medicine, 1987
Academy of Breastfeeding Medicine
American Academy of Family Physicians
American Public Health Association
California Academy of Family Physicians
North American Primary Care Research Group
Society for Medical Decision Making
Society of Teachers of Family Medicine
Select Recent Publications
Melnikow J, McGahan C, Sawaya G, Ehlen T, Coldman A. Cervical intraepithelial neoplasia outcomes after treatment: Long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009 ;101:721-8.
Melnikow J, Birch S, Slee C, McCarthy TJ, Helms LJ, Kuppermann M. Tamoxifen for Breast Cancer Risk Reduction: Impact of Alternative Approaches to Quality-of-Life Adjustment on Cost Effectiveness Analysis. Med Care. 2008;46(9):946-53.
Franks P, Lubetkin EI, Melnikow J. Do personal and societal preferences differ by sociodemographic group? Health Econ. 2007;16:319-25.
Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests. Obstetrics & Gynecology 2006; 107:2:321-328.
Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J. Chemoprevention: Drug Pricing and Mortality -- The Case of Tamoxifen. Cancer 2006; 107:950-58.
Melnikow J, Paterniti 0, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S. Preferences of women evaluating risks of tamoxifen. Cancer 2005; 103: 1996-2005.
Paterniti DA, Melnikow J, Nuovo J, Henderson S, DeGregorio M, Kuppermann M, Nease R. "I'm Going To Die of Something Anyway": Women's Perceptions of Tamoxifen for Breast Cancer Risk Reduction. Ethnicity & Disease 2005; 15:365-372.
Keyser JF, Melnikow J, Kupperman M, Birch S, Kuenneth C, Nuovo J, Azari R, Oto-Kent 0, Rooney M. Recruitment Strategies for Minority Participation: Challenges and Cost Lessons from the POWER Interview study. Ethnicity & Disease 2005; 15:395-406.
Kravitz RL, Melnikow J. Medical adherence research: time for a change in direction? Med Care 2004;42:197-9.